Navigation Links
UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development

University of California, San Diego Health Sciences leaders have announced that they have executed a formal Memorandum of Understanding (MOU) with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), with the objective of developing future collaborations in biomedical research and education to advance human health.

The MOU establishes a framework for future research and training efforts between the UC San Diego School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences and the UC San Diego Medical Center health system, and J&JPRD, a pharmaceutical research and development company with expertise in small molecules, genomics, bioinformatics, high throughput screening, and structural biology.

"We are excited about this tremendous opportunity to partner with J&JPRD, which is a world leader in the development of new drugs. This collaboration will further accelerate our efforts at UC San Diego to translate the exciting discoveries being made every day in our laboratories into improved diagnostic and treatment technologies that benefit all patients," said David Brenner, M.D., UC San Diego Vice Chancellor for Health Sciences. "The ability to work more closely with colleagues in the private sector will strengthen our translational research program, and enhance the education of our medical, pharmacy and graduate students, in addition to boosting the potential for new product development."

Brenner joined with G. Diego Miralles, M.D., Head and Chief Medical Officer of J&JPRD's Research and Early Development unit based in San Diego, to sign the MOU in ceremonies at the UC San Diego School of Medicine.

Echoing Dr. Brenner's enthusiasm, Dr. Miralles noted that "academia and industry are natural partners since we have complimentary expertise and share the common goal of addressing unmet medical needs. Working closely with our neighbors at UCSD will help us find win-win opportunities and maximize our common capabilities. We are very excited about the potential of this partnership."

The two organizations plan to create education, training and research collaborations in biomedical science, medicine and public health, with a focus on projects that lead to new clinical applications. In addition to signing the MOU, the organizations also signed the first agreement between UC San Diego Health Sciences and J&JPRD under the MOU framework a contract for UC San Diego Professor of Pharmacology Larry Brunton, Ph.D., to conduct laboratory studies to evaluate the effects of new compounds on heart tissue.


Contact: Leslie Franz
University of California - San Diego

Related medicine news :

1. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
2. Centennial Taking Control of Your Diabetes Conference Returns to San Diego to Bring Answers, Advocacy and Hope
3. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
4. Car Donations: "Tired Wheels" Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego
5. UC San Diego to lead nationwide program in pharmacogenomics
6. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
7. Graves & Thyroid Disease National Patient Conference Set for San Diego, CA
8. Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008
9. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
10. San Diego Supercomputer Center director urges academia to make cyberinfrastructure real
11. CRH Medical Corporation opens Center in San Diego California
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Volpara ... breast density assessment and enterprise analytics solutions, here at the 101st Annual ... Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements of ...
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... Sikka ... New York Dental Meeting. Their Ecosystem empowers dentists to make complex business decisions by ... the booth will receive a free fee survey with 10 procedures customized by zip ...
(Date:11/30/2015)... ... , ... Scott Newman MD, FACS of New York’s Advanced ... in the New York City area to utilize the new, non-invasive SculpSure™ Laser ... treatment for fat loss in the abdomen, flanks, and other areas that is ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... today released the results of a survey of educational needs for pharmacists worldwide. ... a growing global demand for high quality online and face-to-face education for pharmacists ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announces the Unstoppable Swappables, a household invention that provides an economical and easy ... a year and is growing at 2.6%," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , November 30, 2015 Mexico Healthcare ... and Life Sciences Report 2015 . --> Pharmaboardroom releases ... . Latin America , a country of ... , a country of over 122 million people. --> ... healthcare, pharmaceuticals, or life sciences insights into the second largest pharma ...
(Date:11/29/2015)... AMSTERDAM , Nov. 29, 2015   Royal ... data driven radiology solutions at the 2015 Radiological Society ... December 4 at McCormick Place in Chicago ... will experience the company,s broad portfolio of integrated ... Management solutions to increase clinical performance, improve workflow and ...
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
Breaking Medicine Technology: